deltatrials
Completed PHASE2 NCT00849264

Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients

a Randomized Controlled Study of Surgical Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients

Sponsor: Eastern Hepatobiliary Surgery Hospital

Conditions Hepatocellular Carcinoma Portal Vein Tumor Thrombus
Interventions chemotherapy with endostar treatment with CBP and 5-FU treatment with endostar, CBP and 5-FU
Updated 5 times since 2017 Last updated: Mar 30, 2016 Started: Dec 31, 2008 Primary completion: Dec 31, 2009 Completion: Dec 31, 2010

This PHASE2 trial investigates Hepatocellular Carcinoma and Portal Vein Tumor Thrombus and is currently completed. Eastern Hepatobiliary Surgery Hospital leads this study, which shows 5 recorded versions since 2008 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Dec 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Eastern Hepatobiliary Surgery Hospital
Data source: Eastern Hepatobiliary Surgery Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Shanghai, China